Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantation

doi:10.5306/wjco.v16.i4.100729

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (425)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

184

Figures (1-3)

Tables (1-3)

Sum=339

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=67

Apr 24, 2025 (publication date) through Apr 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Apr 24, 2025; 16(4): 100729
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.100729

Open in New Tab Full Size Figure Download Figure

Figure 1 Multidisciplinary tumor board vs non-multidisciplinary tumor board. A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.

Open in New Tab Full Size Figure Download Figure

Figure 2 Multidisciplinary tumor board vs non-multidisciplinary tumor board. These results indicate patients that were within the University of California, San Francisco (UCSF) criteria. A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.

Open in New Tab Full Size Figure Download Figure

Figure 3 Multidisciplinary tumor board vs non-multidisciplinary tumor board. These results indicate patients that exceeded the University of California, San Francisco (UCSF) criteria. A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.

Citation: Zhang L, Yang J, Li JJ, Chen CY, Wang XD, Xie Y, Jiang WT. Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantation. World J Clin Oncol 2025; 16(4): 100729
URL: https://www.wjgnet.com/2218-4333/full/v16/i4/100729.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i4.100729